AFP and hepatocellular carcinoma: As mentioned above, ROC curve analysis showed that the optimal cut-off levels of AFP for predicting HCC development were ≥ 10.5 ng/mL and ≥ 5.6 ng/mL, at the start and end of DAA therapy, respectively.